Needham & Company Starts Zealand Pharma A/S (ZEAL) at Buy

Go back to Needham & Company Starts Zealand Pharma A/S (ZEAL) at Buy

Guggenheim Starts Zealand Pharma A/S (ZEAL) at Buy

September 5, 2017 6:14 AM EDT

Guggenheim initiates coverage on Zealand Pharma A/S (NASDAQ: ZEAL) with a Buy rating and a price target of $28.00.

For an analyst ratings summary and ratings history on Zealand Pharma A/S... More

Morgan Stanley Starts Zealand Pharma A/S (ZEAL) at Overweight

September 5, 2017 3:30 AM EDT

Morgan Stanley initiates coverage on Zealand Pharma A/S (NASDAQ: ZEAL) with a Overweight rating and a price target of $28.00.

For an analyst ratings summary and ratings history on Zealand Pharma A/S... More